Home » Tenders » Americas » USA » Tender 145545737

Development of a Formulationagnostic Autoinjector Tender - 145545737

The DEPT OF DEFENSE | DEPT OF THE ARMY has issued a Tender notice for the procurement of a Development of a Formulationagnostic Autoinjector Platform in the USA. This Tender notice was published on 21 Jul 2026 and is scheduled to close on 07 Aug 2026, with an estimated Tender value of Refer Document. Interested bidders can access detailed Tender information, eligibility criteria, and complete bidding documents by referencing TOT Ref No. 145545737, while the tender notice number is W911SR-26-PLATFORM and Registering on the platform.

Procurement Summary

Country: USA

Summary: Development of a Formulationagnostic Autoinjector Platform

Deadline: 07 Aug 2026

Posting Date: 21 Jul 2026

Other Information

Notice Type: Tender

TOT Ref.No.: 145545737

Document Ref. No.: W911SR-26-PLATFORM

Competition: ICB

Financier: Self Financed

Purchaser Ownership: Public

Tender Value: Refer Document

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_details

Tender Details

The Department of War (DoW), Capability Program Executive for Chemical, Biological, Radiological and Nuclear Defense (CPE CBRND), Joint Project Manager for CBRN Medical (JPM CBRN Medical) is seeking information, design concepts, and capabilities for a Formulation-Agnostic Autoinjector Platform.
The goal of this initiative is to identify or develop a modular, ruggedized, and highly reliable autoinjector device capable of delivering single-chamber liquid, dual-chamber liquid-liquid, or dual-chamber solid-liquid (reconstitution) formulations.
Key Technical Parameters & Scope:
Reliability: Must design toward or meet an FDA-validated reliability threshold of 99.999% over the product lifecycle.
Flexibility: Capable of delivering volumes ranging from 0.4 mL to 2.0 mL (Threshold) up to 5.0 mL (Objective) across varying fluid viscosities without design modifications to the primary assembly line.
Ruggedization: Capable of meeting or being ruggedized to MIL-STD-810H standards, ensuring intramuscular (IM) delivery through Mission Oriented Protective Posture (MOPP) gear and Army Combat Uniforms (ACU).
Target Compounds: Initial candidates include Atropine, Pralidoxime Chloride (2-PAM), Midazolam, and Naloxone.
Commercialization: The Government seeks platform designs with clear dual-use pathways for sustainable commercial market viability beyond military procurement.
This RFI is for market research and planning purposes only. It does not constitute a solicitation, nor does it restrict the Government's ultimate acquisition strategy.
Notice ID: w911sr-26-platform

Department/Ind. Agency: dept of defense

Sub-tier: dept of the army

Office: w6qk acc-apg

Product Service Code: 6515 - medical and surgical instruments, equipment, and supplies

NAICS Code: 339112 - Surgical and Medical Instrument Manufacturing

Inactive Dates: aug 22, 2026

Inactive Policy: 15 days after response date

Documents

Tender Notice

Documents.zip

Download All

Corresponding Contract Award Notice

No Contract Award Notice found for this tender. Please try using the Contract Award Search Page.

Browse More

All Tenders From USA

All Tenders From Americas

Procurement Documents for USA

Access a comprehensive library of standard procurement documents specific to USA. Here, you'll find all the essential forms, guidelines, and templates required for tender applications and submissions in USA

Explore Procurement Documents for USA

Want To Bid in This Tender?

Get Local Agent Support in USA and 60 More Countries.

View All The Services

View Tenders By